Frameshift mutations are among the most disruptive changes that can happen to a gene. Unlike a simple letter swap that might change one amino acid in a protein, a frameshift alters every amino acid downstream of the error by throwing off the three-letter reading pattern cells use to translate DNA into protein. The result is usually a garbled protein that gets cut short by a premature stop signal, and the consequences range from silent cellular cleanup to fatal inherited disease. What makes frameshifts especially interesting is that the same basic error can play very different roles depending on context: destroying a tumor suppressor in cancer, crippling a muscle protein in muscular dystrophy, or even helping a virus regulate its own replication machinery.
How the Reading Frame Works and Why Losing It Matters
Cells read the genetic code in groups of three nucleotides, each triplet specifying one amino acid. Think of it like a sentence made entirely of three-letter words: “THE CAT ATE THE RAT.” If you delete the first letter, every word boundary shifts and the sentence becomes nonsense: “HEC ATA TET HER AT.” That is exactly what happens when a nucleotide is inserted or deleted from a protein-coding region in a number that is not a multiple of three. The entire downstream sequence is read in the wrong groups, producing a completely different chain of amino acids until the ribosome hits a premature stop codon and halts translation. The resulting protein, if it is made at all, is almost always nonfunctional.
Insertions add one or more extra nucleotides, deletions remove them, and both cause frameshifts when the number of bases gained or lost is not divisible by three. A two-base insertion, a single-base deletion, a four-base insertion: all of these break the reading frame. A three-base insertion or deletion, by contrast, adds or removes exactly one amino acid without disturbing the rest of the sequence. That distinction matters enormously in clinical genetics, where the difference between an “in-frame” and “out-of-frame” mutation can be the difference between a manageable condition and a devastating one.
What Causes Frameshifts at the Molecular Level
The most common natural source of frameshift mutations is replication slippage, which happens when the DNA-copying machinery stumbles on short repetitive sequences. During replication, the newly synthesized strand can briefly detach from its template and reattach slightly out of register, either looping out a few bases (causing an insertion) or skipping past a few (causing a deletion). Research on this process has shown that slippage involves the DNA polymerase physically pausing within the repeated sequence and then dissociating from the DNA, which gives the strand an opportunity to slip before replication resumes.
1PubMed Central. Replication slippage involves DNA polymerase pausing and dissociationRepetitive DNA stretches called microsatellites are especially vulnerable. These are short sequence motifs repeated in tandem, and the longer the repeat tract, the more prone it is to slippage errors. Studies comparing human microsatellite regions have found that the rate of insertion and deletion mutations increases exponentially with repeat length, gaining more than two orders of magnitude across the range of repeat lengths studied.
2PubMed Central. DNA Slippage Occurs at Microsatellite Loci without Minimal Threshold Length in Humans: A Comparative Genomic ApproachExternal agents can also trigger frameshifts. Intercalating chemicals, such as acridine and its derivatives, wedge themselves between the stacked base pairs in the DNA helix. This distorts the local structure enough that the replication or repair machinery inserts or skips a base, producing frameshifts. Acridine-type intercalators have been studied extensively as frameshift mutagens, particularly in bacterial systems.
3PubMed. Genotoxicity of non-covalent interactions: DNA intercalatorsOxidative stress is another culprit. When cells are exposed to reactive oxygen species, the resulting DNA damage can compound with replication errors to produce insertions and deletions. In mice lacking the mismatch repair gene MSH2, treatment with an oxidizing agent significantly increased the frequency of insertion-deletion mutations in intestinal tissue, and the mutation signatures closely resembled those seen in human mismatch-repair-deficient cancers.
4BioMed Central / Genes and Environment. Oxidative stress accelerates repeat sequence instability and base substitutions promoting gastrointestinal driver mutations in MSH2 deficient miceHow Cells Try to Clean Up the Damage
Because frameshifts almost always introduce a premature stop codon somewhere downstream, cells have a quality-control system designed to catch and destroy the resulting faulty messenger RNA before it gets translated into a toxic or useless protein. This system, called nonsense-mediated mRNA decay, degrades transcripts that carry premature stop signals. It is estimated that nonsense and frameshift mutations generating premature stop codons account for roughly a third of all known human genetic diseases, which gives a sense of how central this cleanup pathway is to human health.
5PubMed Central. Nonsense-mediated mRNA decay: inter-individual variability and human diseaseWhen the decay pathway works properly, it prevents the defective protein from being made, which limits the damage to a simple loss of function: the cell has less of that particular protein than it should. Researchers have confirmed this mechanism in specific disease contexts. In one large family with a heart rhythm disorder called long QT syndrome type 2, a frameshift mutation in the responsible gene produced an mRNA that was actively degraded by nonsense-mediated decay, meaning the faulty transcript never got translated into a misfolded protein.
6PubMed Central. Nonsense-Mediated mRNA Decay Caused by a Frameshift Mutation in a Large Kindred of Type 2 Long QT SyndromeBut the cleanup system is not perfect. Mutations near the end of a gene can escape the decay pathway entirely, because the premature stop codon is close enough to where the natural stop would be that the cell does not recognize anything as wrong.
7PubMed Central. Systematic analysis of variants escaping nonsense-mediated decay uncovers candidate Mendelian diseasesWhen a frameshift-truncated protein escapes decay and actually gets made, the results can be worse than simply losing the protein. Abnormal proteins may misfold and clump together into aggregates that actively harm the cell. Frameshift mutations in the HSPB8 gene, for instance, produce mutant proteins sharing an abnormal tail region that makes them highly insoluble. These aggregates interfere with the cell’s protein-disposal machinery and have been linked to neuromuscular disease.
8PubMed Central. HSPB8 frameshift mutant aggregates weaken chaperone-assisted selective autophagy in neuromyopathiesA similar story plays out in ALS, the motor neuron disease. Certain frameshift mutations in the FUS gene produce truncated proteins tacked onto short novel peptide sequences. These frameshift-derived peptides can alter where the truncated protein ends up inside the cell and increase its tendency to aggregate, which may help explain why patients carrying different frameshift mutations in the same gene sometimes have very different disease courses.
9PubMed Central. Frameshift peptides alter the properties of truncated FUS proteins in ALS-FUSInherited Diseases Driven by Frameshifts
Several well-known genetic diseases illustrate the clinical impact of frameshift mutations, and the most instructive example is probably the pair of conditions caused by mutations in the dystrophin gene. Duchenne muscular dystrophy is a severe, progressive muscle-wasting disease that typically confines boys to a wheelchair by their early teens. Becker muscular dystrophy affects the same gene but follows a much milder course. The key distinction is the reading frame. Out-of-frame mutations, which cause a frameshift and abolish dystrophin production, lead to Duchenne. In-frame mutations, which shorten the protein but preserve the reading frame, lead to the milder Becker phenotype.
10PubMed Central. Low-level dystrophin expression attenuating the dystrophinopathy phenotypeThis “reading frame rule” has been validated in a large analysis of 258 independent deletions at the dystrophin gene locus, where the predicted correlation between in-frame versus out-of-frame status and clinical severity held true in 92% of cases.
11PubMed Central. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletionThe remaining 8% includes cases where low levels of dystrophin are still produced despite a frameshift, or where other compensatory mechanisms soften the expected severity. Still, the reading frame rule is the single most powerful predictor of disease severity in dystrophinopathy, and it forms the basis for the therapeutic strategy discussed later.
Tay-Sachs disease offers another example. The most common mutation worldwide in the responsible gene is a four-base insertion in exon 11, which shifts the reading frame and creates a premature stop codon.
12PubMed Central. The molecular basis of HEXA mRNA deficiency caused by the most common Tay-Sachs disease mutationThe resulting loss of enzyme activity allows a fatty substance to build up in nerve cells, leading to rapid neurological deterioration in infancy. Dozens of different mutations in the same gene can cause Tay-Sachs, including point mutations and deletions, but the frameshift insertion accounts for a disproportionate share of cases.
13Human Mutation. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A geneCystic fibrosis is usually associated with the well-known delta-F508 mutation (a three-amino-acid deletion that is technically in-frame), but several frameshift mutations also cause the disease. Two frameshift mutations identified in exon 7 of the CFTR gene, one a two-nucleotide insertion and the other a single-nucleotide deletion, both shift the reading frame and introduce premature stop codons around residue 368-369, producing severely truncated, nonfunctional versions of the chloride channel protein.
14PubMed Central. Two frameshift mutations in the cystic fibrosis geneAnother frameshift mutation in exon 13 introduces a stop codon at residue 821.
15Nature. A frame-shift mutation in the cystic fibrosis geneAll of these produce proteins too short to function, leading to the thick mucus buildup, lung infections, and digestive problems characteristic of cystic fibrosis.
Frameshifts in Cancer
Frameshift mutations play a distinct and somewhat paradoxical role in cancer. On one hand, they can disable tumor-suppressor genes and drive cancer development. On the other, the abnormal proteins they generate can make tumors more visible to the immune system, which has implications for treatment.
The connection between frameshifts and cancer is especially tight in tumors with deficient mismatch repair, the DNA proofreading system that normally corrects replication slippage errors. When mismatch repair fails, microsatellite sequences throughout the genome accumulate insertions and deletions at a high rate, a condition known as microsatellite instability. This is the hallmark of Lynch syndrome, an inherited cancer predisposition caused by mutations in mismatch repair genes. The resulting frameshift mutations hit genes involved in DNA repair, cell signaling, programmed cell death, and other critical functions.
16PubMed. Microsatellite instability: an updateFrameshifts also contribute to cancer through the inactivation of BRCA1 and BRCA2, the DNA repair genes most famously associated with breast and ovarian cancer. A pan-cancer analysis found that roughly 60% of tumors showing a specific pattern of DNA repair deficiency could be explained by the loss of both copies of BRCA2, BRCA1, RAD51C, or PALB2, with the inactivation most often caused by a combination of a pathogenic variant or frameshift plus loss of the other gene copy.
17Nature Communications. Pan-cancer landscape of homologous recombination deficiencyThe paradox is that frameshift mutations produce scrambled protein sequences that the immune system has never encountered. In microsatellite-unstable colorectal cancers, mismatch repair deficiency leads to the translation of novel frameshift peptides that can act as neoantigens, targets that immune cells recognize as foreign.
18PubMed Central. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndromeThis enhanced immunogenicity is one reason why tumors with high microsatellite instability tend to respond well to immune checkpoint inhibitors, a class of cancer drugs that essentially remove the brakes from the immune system. Research into the pan-cancer landscape of frameshift mutations has confirmed that these mutations can generate neoantigens and enhance immune responses even in cancers with otherwise low overall mutation counts.
19PubMed Central. Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burdenTherapeutic Strategies That Work Around Frameshifts
Because frameshifts are so destructive, some of the most innovative genetic therapies in development aim not to fix the mutation directly but to restore the reading frame by skipping over the damaged region. This approach, called exon skipping, uses short synthetic molecules called antisense oligonucleotides that bind to the pre-mRNA and trick the splicing machinery into removing an extra exon. If the removed exon restores the reading frame, the cell produces a shorter-than-normal but partially functional protein instead of no protein at all.
The best-developed example is in Duchenne muscular dystrophy. Since the disease is caused by out-of-frame mutations that destroy dystrophin production, the therapeutic goal is to convert the reading frame from out-of-frame to in-frame, essentially converting a Duchenne-type mutation into a Becker-type mutation. Several exon-skipping drugs targeting different exons in the dystrophin gene have received regulatory approval or are in late-stage trials.
20PubMed Central. Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular DystrophyThe same strategy is being explored for other diseases. In cystic fibrosis, researchers have shown that skipping exon 23 of the CFTR gene produces a shortened protein that retains partial function and still responds to modulator drugs already in clinical use for other CF mutations.
21PubMed Central. Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosisFor a form of inherited blindness called retinitis pigmentosa 11, caused by frameshift mutations in the PRPF31 gene, antisense-induced skipping of exon 12 rescued the reading frame and boosted the gene’s expression to levels that met the predicted threshold for a therapeutic benefit.
22PubMed Central. A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31Gene editing using CRISPR-Cas9 takes a different approach. Rather than restoring a broken reading frame, CRISPR-based gene knockout deliberately introduces frameshifts to disable a target gene. The editing machinery cuts the DNA at a specified location, and the cell’s imprecise repair process introduces small insertions or deletions that shift the reading frame and trigger nonsense-mediated decay of the resulting transcript.
23PubMed Central. CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulationThis is how researchers routinely knock out genes in the laboratory, and it is the basis for several therapeutic CRISPR approaches aimed at silencing disease-causing genes. The irony is clear: the same type of mutation that causes so many genetic diseases is now being engineered on purpose as a treatment tool.
Programmed Frameshifting in Viruses
Not all frameshifts are accidents. Hundreds of RNA viruses deliberately use a process called programmed ribosomal frameshifting during translation of their genomes. The virus encodes specific RNA structures, typically a slippery sequence followed by a complex folded element called a pseudoknot, that cause the ribosome to shift backward by one nucleotide at a defined spot. This controlled slip means that a fraction of the ribosomes translating a viral gene switch into a different reading frame partway through, producing a longer fusion protein instead of the shorter one.
24PubMed Central. Structural and Functional Insights into Viral Programmed Ribosomal FrameshiftingThe purpose is to control the ratio between two proteins that the virus needs in different amounts. By setting the frameshifting efficiency at, say, 20%, the virus ensures it makes five times more of the upstream protein than the downstream one, maintaining the stoichiometry needed for productive infection.
25PubMed Central. Regulators of Viral Frameshifting: More Than RNA Influences Translation EventsSARS-CoV-2, the virus responsible for COVID-19, relies on this exact mechanism. Programmed frameshifting during translation of its RNA genome is required for the virus to produce its RNA-copying enzyme and other essential downstream proteins.
26PubMed Central. Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genomeBecause the virus cannot replicate without this frameshifting event, the RNA structures that trigger it are potential drug targets. Compounds that jam the pseudoknot or prevent the ribosomal slip could, in theory, shut down viral replication without directly targeting the viral polymerase.
Frameshifts as an Evolutionary Force
Given how devastating frameshifts usually are, it might seem odd to suggest they play a constructive role in evolution. But accumulating evidence suggests that tolerated frameshifts have contributed substantially to the emergence of new genes and proteins. Computational analyses have identified hundreds of cases in the human and mouse genomes where frameshift events appear to have given rise to new gene segments, suggesting that frameshift changes are a prevalent mechanism for the rapid emergence of novel protein-coding sequences from existing exons.
27PubMed. Frequent appearance of novel protein-coding sequences by frameshift translationOne reason this works better than you might expect involves the chemistry of the genetic code itself. Research has shown that when a protein sequence undergoes a frameshift, key physical and chemical properties of the original sequence are often preserved in the new one. Hydrophobicity patterns, charge distributions, and structural tendencies carry over to a surprising degree. This means a frameshift can produce a protein that is radically different in its amino acid sequence yet retains enough of the original’s physical character to fold and function.
28PubMed Central. Frameshifting preserves key physicochemical properties of proteinsThe implication is striking: frameshifts allow evolution to make large jumps through protein sequence space while carrying some of the already-optimized physical properties along for the ride. Most of these jumps land nowhere useful and get weeded out by natural selection. But occasionally one lands on a functional sequence, and a new protein capability is born.
Even at the cellular level, frameshift suppression has been documented. In yeast, a suppressor transfer RNA carrying a four-base anticodon can read a four-base codon in the mRNA, effectively correcting a frameshift during translation and restoring the original reading frame downstream.
29PubMed. The yeast frameshift suppressor gene SUF16-1 encodes an altered glycine tRNA containing the four-base anticodon 3′-CCCG-5′This kind of translational workaround is rare in nature, but its existence hints at the flexibility built into the genetic code, a system rigid enough to function reliably yet loose enough to accommodate and sometimes exploit errors that would seem fatal on paper.